# Informing the Population of Their Level of Protection Against COVID-19 in Monaco: a Prospective Study (MonaVacc)

> **NCT05084950** · — · UNKNOWN · sponsor: **Centre Scientifique de Monaco** · enrollment: 10000 (estimated)

## Conditions studied

- SARS-CoV-2
- COVID-19
- Vaccines
- Antibody

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05084950
- **Lead sponsor:** Centre Scientifique de Monaco
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2021-10-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05084950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05084950, "Informing the Population of Their Level of Protection Against COVID-19 in Monaco: a Prospective Study (MonaVacc)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05084950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*